|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nashimoto A, Akazawa K, Isobe Y, Miyashiro
I, Katai H, Kodera Y, Tsujitani S, Seto Y, Furukawa H, Oda I, et
al: Gastric cancer treated in 2002 in Japan: 2009 annual report of
the JGCA nationwide registry. Gastric Cancer. 16:1–27. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus
surgery alone for resectable gastroesophageal cancer. N Engl J Med.
355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshikawa T, Sasako M, Yamamoto S, Sano T,
Imamura H, Fujitani K, Oshita H, Ito S, Kawashima Y and Fukushima
N: Phase II study of neoadjuvant chemotherapy and extended surgery
for locally advanced gastric cancer. Br J Surg. 96:1015–1022. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ychou M, Boige V, Pignon JP, Conroy T,
Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM,
Saint-Aubert B, et al: Perioperative chemotherapy compared with
surgery alone for resectable gastroesophageal adenocarcinoma: An
FNCLCC and FFCD multicenter phase III trial. J ClinOncol.
29:1715–1721. 2011. View Article : Google Scholar
|
|
7
|
Tsuburaya A, Mizusawa J, Tanaka Y,
Fukushima N, Nashimoto A and Sasako M; Stomach Cancer Study Group
of the Japan Clinical Oncology Group, : Neoadjuvant chemotherapy
with S-1 and cisplatin followed by D2 gastrectomy with para-aortic
lymph node dissection for gastric cancer with extensive lymph node
metastasis. Br J Surg. 101:653–660. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Japanese Gastric Cancer Association, .
Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric
Cancer. 20:1–19. 2017. View Article : Google Scholar
|
|
9
|
Inaki N, Etoh T, Ohyama T, Uchiyama K,
Katada N, Koeda K, Yoshida K, Takagane A, Kojima K, Sakuramoto S,
et al: A Multi-institutional, prospective, phase II feasibility
study of laparoscopy-assisted distal gastrectomy with D2 lymph node
dissection for locally advanced gastric cancer (JLSSG0901). World J
Surg. 39:2734–2741. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hur H, Lee HY, Lee HJ, Kim MC, Hyung WJ,
Park YK, Kim W and Han SU: Efficacy of laparoscopic subtotal
gastrectomy with D2 lymphadenectomy for locally advanced gastric
cancer: The protocol of the KLASS-02 multicenter randomized
controlled clinical trial. BMC Cancer. 15:3552015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
In H, Solsky I, Palis B, Langdon-Embry M,
Ajani J and Sano T: Validation of the 8th Edition of the AJCC TNM
staging system for gastric cancer using the national cancer
database. Ann Surg Oncol. 24:3683–3691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mandard AM, Dalibard F, Mandard JC, Marnay
J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P and Samama
G: Pathologic assessment of tumor regression after preoperative
chemoradiotherapy of esophageal carcinoma. Clinicopathologic
correlations. Cancer. 73:2680–2686. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
National Comprehensive Cancer Network, .
NCCN Clinical Practice Guidelines in Oncology Gastric Cancer
(version 2.2018). National Comprehensive Cancer Network. (Fort
Washington, DC). 2018.
|
|
15
|
Lee J and Kim W: Long-term outcomes after
laparoscopy-assisted gastrectomy for advanced gastric cancer:
Analysis of consecutive 106 experiences. J Surg Oncol. 100:693–698.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Du XH, Li R, Chen L, Shen D, Li SY and Guo
Q: Laparoscopy-assisted D2 radical distal gastrectomy for advanced
gastric cancer: Initial experience. Chin Med J (Engl).
122:1404–1407. 2009.PubMed/NCBI
|
|
17
|
Yu J, Hu J, Huang C, Ying M, Peng X, Wei
H, Jiang Z, Du X, Liu Z, Liu H, et al: The impact of age and
comorbidity on postoperative complications in patients with
advanced gastric cancer after laparoscopic D2 gastrectomy: Results
from the Chinese laparoscropic gastrointestinal surgery study
(CLASS) group. Eur J Surg Oncol. 39:1144–1149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu Y, Ying M, Huang C, Wei H, Jiang Z,
Peng X, Hu J, Du X, Wang B, Lin F, et al: Oncologic outcomes of
laparoscopy-assisted gastrectomy for advanced gastric cancer: A
large-scale multicenter retrospective cohort study from China. Surg
Endosc. 28:2048–2056. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J,
Xue Y, Suo J, Tao K, He X, et al: Morbidity and mortality of
laparoscopic versus open D2 distal gastrectomy for advanced gastric
cancer: A randomized controlled trial. J Clin Oncol. 34:1350–1357.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Z, Shan F, Wang Y, Li S, Jia Y, Zhang
L, Yin D and Ji J: Laparoscopic versus open distal gastrectomy for
locally advanced gastric cancer after neoadjuvant chemotherapy:
Safety and short-term oncologic results. Surg Endosc. 30:4265–4271.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kinoshita T and Kaito A: Current status
and future perspectives of laparoscopic radical surgery for
advanced gastric cancer. Transl Gastroenterol Hepatol. 2:432017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li C, Oh SJ, Kim S, Hyung WJ, Yan M, Zhu
ZG and Noh SH: Macroscopic Borrmann type as a simple prognostic
indicator in patients with advanced gastric cancer. Oncology.
77:197–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lauren P: The two histologic main types of
gastric carcinoma: Diffuse and so-called intestinal type carcinoma,
an attempt at a histo-clinical classification. Acta Parhol Microb
Scan. 64:31–49. 1965. View Article : Google Scholar
|
